Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011 Apr;21(2):128-31.
doi: 10.4103/0971-4065.78064.

Cytomegalovirus and Leishmania donovani coinfection in a renal allograft recipient

N Prasad  1 , A Gupta, R K Sharma, S Gopalakrishnan, V Agrawal, M Jain
Affiliations
Case Reports

Cytomegalovirus and Leishmania donovani coinfection in a renal allograft recipient

N Prasad et al. Indian J Nephrol. 2011 Apr.

Abstract

Infection is a leading cause of death in renal allograft recipients. Apart from the immunosuppressive drugs, immunomodulatory viral infections also predispose the recipient to many opportunistic infections. Kala-azar in renal allograft recipients is infrequently reported even in endemic areas. In majority of cases, there was delay in diagnosis and treatment. We report a case of renal allograft recipient, where we faced a diagnostic dilemma because of coinfection of cytomegalovirus and visceral leishmaniasis (kala-azar). Kala-azar was successfully treated with amphotericin B. Kala-azar should always be kept as differential diagnosis in patients with pyrexia and cytopenia, even in the absence of splenomegaly in patients residing in an endemic zone.

Keywords: Cytomegalovirus infection; kala-azar; renal transplantation.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Morphological examination of bone marrow aspirate showing Leishmania donovani bodies
See this image and copyright information in PMC

References

    1. Peterson PK, Anderson RC. Infection in renal transplant recipient, Current approach to diagnosis, therapy and prevention. Am J Med. 1986;81:2–10. - PubMed
    1. Berenguer J, Gomez-campdera F, Padilla B, Rodriguez Ferrero M, Anaya F, Moreno S, et al. Visceral Leishmaniasis (Kala-azar) in solid organ transplants: case report and review. Transplantation. 1998;65:1401–4. - PubMed
    1. Hernández-Pérez J, Yebra-Bango M, Jiménez-Martínez E, Sanz-Moreno C, Cuervas-Mons V, Alonso Pulpón L, et al. Visceral Leishmaniasis (Kala-azar) in solid organ transplants: report of five cases and review. Clin Infect Dis. 1999;29:918–21. - PubMed
    1. George MJ, Snydman DR, Werner BG, Griffith J, Falagas ME, Dougherty NN, et al. The independent role of Cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston center for liver transplantation CMVIG- study group. Cytogam, MedImmune,Inc. Maryland. Am J Med. 1997;103:106–13. - PubMed
    1. Sabbatini M, Pisani A, Ragosta A, Gallo R, Borrelli F, Cianciaruso B. Visceral leishmaniasis in renal transplant recipients. Is it still a challenge to the nephrologist? Transplantation. 2002;73:299–301. - PubMed

Publication types